• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » Sectra’s First-Quarter Interim Report: Sectra Completes Mammography Modality Transaction

Sectra’s First-Quarter Interim Report: Sectra Completes Mammography Modality Transaction

September 14, 2011 By MassDevice

LINKÖPING, Sweden–(BUSINESS WIRE)–Regulatory News:

“The unique low-radiation mammography technology that we have developed
and introduced on the market will receive broad international
distribution and benefit many women. In addition to the capital gain,
the transaction with Philips will contribute favorably to the Group’s
operating profit this financial year”

IT and medical technology company Sectra’s (STO:SECTB) profit after net
financial items for the company’s first quarter, May – July 2011, rose
25.6% to SEK 16.2 million (12.9), corresponding to a profit margin of
9.6% (7.5). The Group reports an operating profit of SEK 6.5 million
(9.0) and net sales of SEK 169.3 million (172.8). Order bookings rose
13.8% to SEK 190.8 million (167.7).

The reported outcome pertains to Sectra’s remaining operations and does
not include Sectra’s modality operations in digital mammography that
were acquired by Royal Philips Electronics. The agreement was signed in
June and the transaction was finalized on August 31. The cash purchase
consideration on a debt-free basis was EUR 57.5 million. The agreement
includes an additional purchase sum of EUR 12.5 million, which falls due
after five years if specially agreed conditions are met.

“The unique low-radiation mammography technology that we have developed
and introduced on the market will receive broad international
distribution and benefit many women. In addition to the capital gain,
the transaction with Philips will contribute favorably to the Group’s
operating profit this financial year,” says Jan-Olof Brüer, President
and CEO of Sectra AB.

In the U.S., uncertainty surrounding the current budgetary savings has
had a dampening effect on the market. Sectra experiences that the sales
process is taking longer than before, which is delaying orders for new
projects.

“The economic trend will determine the size of our customers’
investments. Budgetary savings are affecting our customers within
healthcare as well as authorities and defense. However, Sectra products
and services contribute to enhance efficiency and save expenses in
customers’ operations, which in the long term will imply continued
growth in our markets,” says Jan-Olof Brüer.

The transaction with Philips will create greater opportunities and
increased resources for Sectra to expand its operations.

“A large portion of Sectra’s current revenues is generated by existing
customers, in the form of additional sales and long-term agreements for
products, services, support and upgrades. These customers give us a
solid base for continued expansion. Increased sales of systems, products
and services, combined with the work we carry out to make the
installations and upgrades of our medical systems more efficient, will
determine when we achieve our profit target of 15%.”

The information in this press release is such that Sectra AB (publ) is
obligated to disclose in compliance with the Swedish Securities and
Clearing Operations Act. The information was submitted for publication
on September 6, 2011 at 08:00 a.m. (CET).

About the Sectra Group

Sectra was founded in 1978 and conducts successful development and sales
of high-technology products in the expansive niche segments of medical
systems and secure communication systems. Sectra has offices in 12
countries and sells its products through partners worldwide. The head
office is in Linköping, Sweden, and the company developed from research
at Linköping University. Sales for the 2010/2011 full year amounted to
SEK 784 million. Sectra is listed on the NASDAQ OMX Stockholm AB
exchange. For more information about Sectra, visit our website at http://www.sectra.com.

This information was brought to you by Cision http://www.cisionwire.com

Contacts

Sectra AB
Dr. Jan-Olof Brüer, CEO and President
tel 46 13 23
52 09

Filed Under: MassDevice Earnings Roundup, Wall Street Beat Tagged With: Q2, Sectra

In case you missed it

  • Technical Brief – “Understanding the Extensive OEM Benefits of Total Linear Motion Solutions.”
  • Exactech launches total hip arthroplasty system
  • Lensar announces first patients treated with Ally adaptive cataract treatment
  • HeartBeam submits heart attack diagnostic platform for FDA 510(k) clearance
  • GE Healthcare leads AliveCor Series F funding for ECG tech
  • New FDA ruling may lower costs for over-the-counter hearing aids
  • Data supports Sight Sciences’ Omni surgical system for glaucoma
  • Integra founder Richard Caruso has died
  • Moximed raises $40M for implantable shock absorber for knee osteoarthritis
  • Philips names Roy Jakobs as CEO amid ventilator, CPAP recalls
  • Shareholder lawsuit over BD’s Alaris pumps recall moves forward
  • Dyad Medical wins FDA clearance for cardiac imaging platform Echo:Prio
  • Outset Medical wins national VA contract
  • Inspire Medical Systems appoints former Zimmer Biomet exec as VP of investor relations
  • Abbott will spend $450M to up FreeStyle Libre production in Ireland
  • Acutus Medical ticks up on revenue beat, missed EPS in Q2 results
  • ResMed expects steady growth over the next year

RSS From Medical Design & Outsourcing

  • What Laura Mauri learned from a ‘firestorm’ in her first months at Medtronic
    Dr. Laura Mauri faced a monumental moment with former Medtronic CEO Omar Ishrak shortly after she joined the company as VP of global clinical research and analytics. It was late 2018, and Mauri — who’s now an SVP and the chief scientific, medical and regulatory officer at Medtronic (NYSE: MDT) — was in a meeting… […]
  • Senators seek post-market FDA study of pulse oximeters and skin color
    Democratic U.S. senators are prodding the FDA to launch a post-market study of pulse oximeters due to unreliable performance for patients with dark skin. Pulse oximeters estimate blood oxygen levels (SpO2) and pulse rates in patients using infrared light — usually on a fingertip — at home or in clinical settings. Blood oxygenation is one… […]
  • TE Connectivity opens global medical device prototyping center in Ireland
    TE Connectivity (NYSE:TEL) today announced it opened its global Propelus Prototype Center for medical devices in Galway, Ireland. The $5 million rapid prototyping center was built into its existing manufacturing site in Galway and directly connects TE engineers with customers to reduce development time and increase speed to market for lifesaving and life-improving medical devices. Propelus… […]
  • Contract manufacturer Minnetronix Medical launches its first in-house product, MindsEye
    Minnetronix Medical has launched MindsEye, making it the first medical device that the contract developer and manufacturer has conceived and commercialized. St. Paul-based Minnetronix Medical’s MindsEye is the first expandable brain access port on the market. The FDA cleared the device under the 510(k) pathway in August 2020. The minimally invasive device gives neurosurgeons deep… […]
  • What’s next for Jennifer Fried after leaving Explorer Surgical?
    Explorer Surgical co-founder Jennifer Fried has resigned from the company after selling it to Global Healthcare Exchange in October. Fried announced her departure last week on LinkedIn, saying she’s preparing for her next professional chapter. “It’s bittersweet — I’m so proud of everything our team has built and accomplished,” Fried wrote. “The time has flown… […]
  • The 24 best medical device innovations of 2022
    The Galien Foundation recently announced its nominees of medical device innovations for its 2022 Prix Galien USA awards. There are 24 medical technologies nominated for the annual award this year, up from 18 nominees in 2021. The Galien Foundation’s annual Prix Galien awards highlight devices, biotechnology and pharmaceutical products designed to improve the human condition.… […]
  • FDA issues new COVID-19 testing guidance to avoid false negatives
    COVID-19 testing should be repeated following a negative result on any antigen test, the FDA said in a move that could increase demand for diagnostics manufacturers. The latest guidance from the federal health agency is for negative COVID-19 antigen test results regardless of the presence or absence of symptoms. The federal agency said recent studies… […]
  • Confluent Medical expands Costa Rica manufacturing footprint for nitinol, complex catheter production
    Confluent Medical Technologies this week announced the opening of its new addition to its Costa Rica manufacturing facility. The expansion adds 66,000 sq. ft to its large-scale manufacturing center of excellence in Alajuela, Costa Rica to expand Confluent’s capacity for nitinol component processing and complex catheter manufacturing. “Confluent has experienced consistent and strong growth in… […]
  • FDA’s breakthrough medical device designations tally nears 700
    Stewart Eisenhart, Emergo Group The US Food and Drug Administration has granted almost 700 designations over the past seven years under a voluntary program for expedited regulatory review of medical devices and combination products that facilitate more effective treatment or diagnosis of serious diseases. According to recent metrics published by FDA, the agency has issued a total of… […]
  • Lifecore Biomedical’s owner plans to go all-in on contract development and manufacturing
    Lifecore Biomedical parent company Landec Corp. (Nasdaq:LNDC) plans to take the subsidiary’s name, leadership and headquarters as its own and sell off food businesses to focus on contract development and manufacturing. Santa Maria, California-based Landec said it will rename itself as Lifecore Biomedical “in the near future” and change its Nasdaq ticker to LFCR. Landec… […]
  • COVID-19 immunity test developers at MIT seek diagnostic manufacturer
    MIT researchers have developed a device for predicting an individual’s COVID-19 immunity and are looking for a diagnostic company to get it manufactured in large numbers and approved by the FDA. The lateral flow test uses the same technology as at-home rapid antigen COVID-19 tests to measure neutralizing antibodies for SARS-CoV-2 in a blood sample,… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy